Dexamethasone (intravitreal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dexamethasone (intravitreal), covering 2022-03-09 to 2022-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular Edema [Phase 3]